艾伯维公司宣布一项重大投资计划,将投入3.8亿美元用于其位于北芝加哥的生产基地。此项投资旨在显著提升其在美国境内的活性药物成分(API)的制造能力,进一步巩固其本土供应链。
通过扩建现有设施,艾伯维致力于加强关键药物的生产保障,确保稳定供应。这一战略举措不仅体现了公司对创新制药的持续承诺,也凸显了其强化美国本土制造业布局的决心。
艾伯维公司宣布一项重大投资计划,将投入3.8亿美元用于其位于北芝加哥的生产基地。此项投资旨在显著提升其在美国境内的活性药物成分(API)的制造能力,进一步巩固其本土供应链。
通过扩建现有设施,艾伯维致力于加强关键药物的生产保障,确保稳定供应。这一战略举措不仅体现了公司对创新制药的持续承诺,也凸显了其强化美国本土制造业布局的决心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.